Seelos Therapeutics Inc (NASDAQ:SEEL)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SEEL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SEEL

  • Market Cap$81.600m
  • SymbolNASDAQ:SEEL
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS81577F1093

Company Profile

Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012.Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company has two product candidates currently in development including Vitaros and RayVa.

Latest SEEL news

Currently there for this company. Visit our news hub for other news .